デフォルト表紙
市場調査レポート
商品コード
1363118

計算生物学の市場規模、シェア、動向分析レポート:サービス別、用途別、最終用途別、地域別、セグメント別予測、2023年~2030年

Computational Biology Market Size, Share & Trends Analysis Report By Service (Database, Infrastructure & Hardware, Software Platform), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 120 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
計算生物学の市場規模、シェア、動向分析レポート:サービス別、用途別、最終用途別、地域別、セグメント別予測、2023年~2030年
出版日: 2023年09月21日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

計算生物学市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界の計算生物学市場規模は2030年までに132億5,000万米ドルに達し、CAGRは13.17%を示すと予測されています。

がん研究分野での研究開発投資の増加、個別化医薬品の需要増加、創薬研究の活発化が市場開拓に寄与すると予測されています。さらに、バイオテクノロジー産業における進歩の増加と人工知能技術の採用は、予測期間中の市場成長をさらに促進します。

遺伝子解析における先端技術の採用拡大が、計算生物学市場の成長を促進しています。例えば、2023年1月、Qiagen Digital Insights(QDI)は、超高速次世代シーケンシング(NGS)解析用に設計された強化製品を発表しました。この革新的なソリューションは、クラウドコンピューティング費用1米ドルで、ゲノム全体をわずか25分以内に処理することを可能にします。これにより研究者は、全ゲノムシーケンス(WGS)、全エクソームシーケンス(WES)、大規模パネルシーケンスなど、さまざまなシーケンスアプローチから得られたデータを効率的に解析・解釈できるようになると予想されます。したがって、予測期間中の市場成長を促進すると予想されます。

さらに、クリプトポリタンが2023年9月に発表した記事によると、大きな進展として、浦項科学技術大学(POSTECH)の科学者が、新薬が臨床試験の前でも承認される可能性を推定するために機械学習を使用したという発見をEBioMedicineジャーナルで共有しました。これは、臨床試験時の薬剤の失敗率を理解するのに役立つと期待されています。このように、技術の進歩の高まりは、予測期間中の市場の成長を促進すると予想されます。

しかし、生物学的システムの複雑さと、この分野における熟練した専門家の不足が、市場の成長を妨げると予想されます。生物学的システムは非常に複雑であり、その挙動を正確にモデル化することは困難であり、熟練した訓練を受けた専門家の存在が必要です。多くの生物学的プロセスには複雑なネットワークや相互作用が関与しているため、解析の複雑さがさらに増し、計算による予測の信頼性が低くなるケースもあります。

計算生物学市場のレポートハイライト

  • サービス別では、ソフトウェア&プラットフォーム分野が2022年に39.06%のシェアで市場を席巻し、予測期間中最も速いCAGRで成長すると予測されています。この背景には、創薬・薬剤開発の増加と個別化医薬品の需要増加があります。
  • 用途別では、臨床試験分野が2022年に26.84%のシェアで市場を独占しました。これは主に、この分野における研究開発イニシアチブの増加によるものです。
  • 最終用途別では、2022年に産業用セグメントが62.10%の最大市場シェアを占めました。これは、創薬、標的同定、仮想スクリーニング、薬物動態モデリングなど、その他の用途における研究活動の増加に起因しています。
  • 2022年には、北米が48.93%のシェアで市場を独占したが、これは大手市場プレイヤーの存在と強固なヘルスケアインフラによるものです。これらは、予測期間中、同地域の計算生物学市場を押し上げると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 変数、動向、範囲

  • 市場系統の見通し
  • 市場動向と展望
  • 市場力学
  • 市場抑制要因分析
  • 事業環境分析

第4章 サービス別ビジネス分析

  • 計算生物学市場:サービス変動分析
  • データベース
  • インフラストラクチャとハードウェア
  • ソフトウェアプラットフォーム

第5章 用途別ビジネス分析

  • 計算生物学市場:用途の変動分析
  • 創薬と疾患モデリング
  • 前臨床薬の開発
  • 臨床試験
  • 計算ゲノミクス
  • 計算プロテオミクス
  • その他

第6章 最終用途別ビジネス分析

  • 計算生物学市場:最終用途の変動分析
  • 学術と研究
  • 産業

第7章 地域別ビジネス分析

  • 地域市場のスナップショット
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 競合情勢

  • 企業の分類
  • 戦略マッピング
  • 企業の市場シェア/地位分析、2022年
  • 企業プロファイル・一覧表
    • DNAnexus, Inc.
    • Illumina, Inc.
    • Thermo Fisher Scientific, Inc.
    • Schrodinger, Inc.
    • Compugen
    • Aganitha AI Inc.
    • Genedata AG
    • QIAGEN
    • SIMULATIONS PLUS
    • Fios Genomics
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America computational biology market, by country, 2018 - 2030 (USD million)
  • Table 4 North America computational biology market, by service, 2018 - 2030 (USD million)
  • Table 5 North America computational biology market, by application, 2018 - 2030 (USD million)
  • Table 6 North America computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 7 U.S. computational biology market, by service, 2018 - 2030 (USD million)
  • Table 8 U.S computational biology market, by application, 2018 - 2030 (USD million)
  • Table 9 U.S computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 10 Canada computational biology market, by service, 2018 - 2030 (USD million)
  • Table 11 Canada computational biology market, by application, 2018 - 2030 (USD million)
  • Table 12 Canada computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 13 Europe computational biology market, by country, 2018 - 2030 (USD million)
  • Table 14 Europe computational biology market, by service, 2018 - 2030 (USD million)
  • Table 15 Europe computational biology market, by application, 2018 - 2030 (USD million)
  • Table 16 Europe computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 17 UK computational biology market, by service, 2018 - 2030 (USD million)
  • Table 18 UK computational biology market, by application, 2018 - 2030 (USD million)
  • Table 19 UK computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 20 Germany computational biology market, by service, 2018 - 2030 (USD million)
  • Table 21 Germany computational biology market, by application, 2018 - 2030 (USD million)
  • Table 22 Germany computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 23 France computational biology market, by service, 2018 - 2030 (USD million)
  • Table 24 France computational biology market, by application, 2018 - 2030 (USD million)
  • Table 25 France computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 26 Italy computational biology market, by service, 2018 - 2030 (USD million)
  • Table 27 Italy computational biology market, by application, 2018 - 2030 (USD million)
  • Table 28 Italy computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 29 Spain computational biology market, by service, 2018 - 2030 (USD million)
  • Table 30 Spain computational biology market, by application, 2018 - 2030 (USD million)
  • Table 31 Spain computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 32 Denmark computational biology market, by service, 2018 - 2030 (USD million)
  • Table 33 Denmark computational biology market, by application, 2018 - 2030 (USD million)
  • Table 34 Denmark computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 35 Sweden computational biology market, by service, 2018 - 2030 (USD million)
  • Table 36 Sweden computational biology market, by application, 2018 - 2030 (USD million)
  • Table 37 Sweden computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 38 Norway computational biology market, by service, 2018 - 2030 (USD million)
  • Table 39 Norway computational biology market, by application, 2018 - 2030 (USD million)
  • Table 40 Norway computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 41 Asia Pacific computational biology market, by country, 2018 - 2030 (USD million)
  • Table 42 Asia Pacific computational biology market, by service, 2018 - 2030 (USD million)
  • Table 43 Asia Pacific computational biology market, by application, 2018 - 2030 (USD million)
  • Table 44 Asia Pacific computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 45 China computational biology market, by service, 2018 - 2030 (USD million)
  • Table 46 China computational biology market, by application, 2018 - 2030 (USD million)
  • Table 47 China computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 48 Japan computational biology market, by service, 2018 - 2030 (USD million)
  • Table 49 Japan computational biology market, by application, 2018 - 2030 (USD million)
  • Table 50 Japan computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 51 India computational biology market, by service, 2018 - 2030 (USD million)
  • Table 52 India computational biology market, by application, 2018 - 2030 (USD million)
  • Table 53 India computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 54 South Korea computational biology market, by service, 2018 - 2030 (USD million)
  • Table 55 South Korea computational biology market, by application, 2018 - 2030 (USD million)
  • Table 56 South Korea computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 57 Australia computational biology market, by service, 2018 - 2030 (USD million)
  • Table 58 Australia computational biology market, by application, 2018 - 2030 (USD million)
  • Table 59 Australia computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 60 Thailand computational biology market, by service, 2018 - 2030 (USD million)
  • Table 61 Thailand computational biology market, by application, 2018 - 2030 (USD million)
  • Table 62 Thailand computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 63 Latin America computational biology market, by country, 2018 - 2030 (USD million)
  • Table 64 Latin America computational biology market, by service, 2018 - 2030 (USD million)
  • Table 65 Latin America computational biology market, by application, 2018 - 2030 (USD million)
  • Table 66 Latin America computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 67 Brazil computational biology market, by service, 2018 - 2030 (USD million)
  • Table 68 Brazil computational biology market, by application, 2018 - 2030 (USD million)
  • Table 69 Brazil computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 70 Mexico computational biology market, by service, 2018 - 2030 (USD million)
  • Table 71 Mexico computational biology market, by application, 2018 - 2030 (USD million)
  • Table 72 Mexico computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 73 Argentina computational biology market, by service, 2018 - 2030 (USD million)
  • Table 74 Argentina computational biology market, by application, 2018 - 2030 (USD million)
  • Table 75 Argentina computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 76 Middle East & Africa computational biology market, by country, 2018 - 2030 (USD million)
  • Table 77 Middle East & Africa computational biology market, by service, 2018 - 2030 (USD million)
  • Table 78 Middle East & Africa computational biology market, by application, 2018 - 2030 (USD million)
  • Table 79 Middle East & Africa computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 80 South Africa computational biology market, by service, 2018 - 2030 (USD million)
  • Table 81 South Africa computational biology market, by application, 2018 - 2030 (USD million)
  • Table 82 South Africa computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 83 Saudi Arabia computational biology market, by service, 2018 - 2030 (USD million)
  • Table 84 Saudi Arabia computational biology market, by application, 2018 - 2030 (USD million)
  • Table 85 Saudi Arabia computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 86 UAE computational biology market, by service, 2018 - 2030 (USD million)
  • Table 87 UAE computational biology market, by application, 2018 - 2030 (USD million)
  • Table 88 UAE computational biology market, by end-use, 2018 - 2030 (USD million)
  • Table 89 Kuwait computational biology market, by service, 2018 - 2030 (USD million)
  • Table 90 Kuwait computational biology market, by application, 2018 - 2030 (USD million)
  • Table 91 Kuwait computational biology market, by end-use, 2018 - 2030 (USD million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market Segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global computational biology market- Key market driver analysis
  • Fig. 7 Global computational biology market - Key market restraint analysis
  • Fig. 8 Global computational biology market - Porter's analysis
  • Fig. 9 Global computational biology market - PESTEL analysis
  • Fig. 10 Global computational biology market: Service outlook key takeaways
  • Fig. 11 Global computational biology market: Service movement analysis
  • Fig. 12 Databases market estimates, 2018 - 2030 (USD Million)
  • Fig. 13 Infrastructure & hardware market estimates, 2018 - 2030 (USD Million)
  • Fig. 14 Software platform market estimates, 2018 - 2030 (USD Million)
  • Fig. 15 Global computational biology market: Application outlook key takeaways
  • Fig. 16 Global computational biology market: Application movement analysis
  • Fig. 17 Drug discovery & disease modeling market estimates, 2018 - 2030 (USD Million)
  • Fig. 18 Target identification market estimates, 2018 - 2030 (USD Million)
  • Fig. 19 Target validation market estimates, 2018 - 2030 (USD Million)
  • Fig. 20 Lead discovery market estimates, 2018 - 2030 (USD Million)
  • Fig. 21 Lead optimization market estimates, 2018 - 2030 (USD Million)
  • Fig. 22 Preclinical drug development market estimates, 2018 - 2030 (USD Million)
  • Fig. 23 Pharmacokinetics market estimates, 2018 - 2030 (USD Million)
  • Fig. 24 Pharmacodynamics market estimates, 2018 - 2030 (USD Million)
  • Fig. 25 Clinical trials market estimates, 2018 - 2030 (USD Million)
  • Fig. 26 Phase I market estimates, 2018 - 2030 (USD Million)
  • Fig. 27 Phase II market estimates, 2018 - 2030 (USD Million)
  • Fig. 28 Phase III market estimates, 2018 - 2030 (USD Million)
  • Fig. 29 Phase IV market estimates, 2018 - 2030 (USD Million)
  • Fig. 30 Computational genomics market estimates, 2018 - 2030 (USD Million)
  • Fig. 31 Computational proteomics market estimates, 2018 - 2030 (USD Million)
  • Fig. 32 Others market estimates, 2018 - 2030 (USD Million)
  • Fig. 33 Global computational biology market: End-use outlook key takeaways
  • Fig. 34 Global computational biology market: End-use movement analysis
  • Fig. 35 Academic & research market estimates, 2018 - 2030 (USD Million)
  • Fig. 36 Industrial market estimates, 2018 - 2030 (USD Million)
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 Global computational biology market: Regional movement analysis
  • Fig. 39 North America computational biology market, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. computational biology market, 2018 - 2030 (USD Million)
  • Fig. 41 Canada computational biology market, 2018 - 2030 (USD Million)
  • Fig. 42 Europe computational biology market, 2018 - 2030 (USD Million)
  • Fig. 43 UK computational biology market, 2018 - 2030 (USD Million)
  • Fig. 44 Germany computational biology market, 2018 - 2030 (USD Million)
  • Fig. 45 France computational biology market, 2018 - 2030 (USD Million)
  • Fig. 46 Spain computational biology market, 2018 - 2030 (USD Million)
  • Fig. 47 Italy computational biology market, 2018 - 2030 (USD Million)
  • Fig. 48 Denmark computational biology market, 2018 - 2030 (USD Million)
  • Fig. 49 Sweden computational biology market, 2018 - 2030 (USD Million)
  • Fig. 50 Norway computational biology market, 2018 - 2030 (USD Million)
  • Fig. 51 Asia Pacific computational biology market, 2018 - 2030 (USD Million)
  • Fig. 52 Japan computational biology market, 2018 - 2030 (USD Million)
  • Fig. 53 China computational biology market, 2018 - 2030 (USD Million)
  • Fig. 54 India computational biology market, 2018 - 2030 (USD Million)
  • Fig. 55 South Korea computational biology market, 2018 - 2030 (USD Million)
  • Fig. 56 Australia computational biology market, 2018 - 2030 (USD Million)
  • Fig. 57 Thailand computational biology market, 2018 - 2030 (USD Million)
  • Fig. 58 Latin America computational biology market, 2018 - 2030 (USD Million)
  • Fig. 59 Brazil computational biology market, 2018 - 2030 (USD Million)
  • Fig. 60 Mexico computational biology market, 2018 - 2030 (USD Million)
  • Fig. 61 Argentina computational biology market, 2018 - 2030 (USD Million)
  • Fig. 62 MEA computational biology market, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa computational biology market, 2018 - 2030 (USD Million)
  • Fig. 64 Saudi Arabia computational biology market, 2018 - 2030 (USD Million)
  • Fig. 65 UAE computational biology market, 2018 - 2030 (USD Million)
  • Fig. 66 Kuwait computational biology market, 2018 - 2030 (USD Million)
  • Fig. 67 Strategy framework
目次
Product Code: 978-1-68038-212-9

Computational Biology Market Growth & Trends:

The global computational biology market size is expected to reach a value of USD 13.25 billion by 2030, according to a new report by Grand View Research, Inc.., exhibiting a CAGR of 13.17%. The growing investments in research & development within the fields of cancer research, increasing demand for personalized medicines, and rising drug discovery & development are anticipated to contribute to the growth of the market. Moreover, the increasing advancements in the biotechnology industry and the adoption of artificial intelligence technology will further drive the market growth over the forecast period.

The growing adoption of advanced technology in gene analysis is propelling the growth of the market for computational biology. For instance, in January 2023, Qiagen Digital Insights (QDI) introduced an enhanced product designed for ultra-rapid next-generation sequencing (NGS) analysis. This innovative solution enables the processing of the entire genome within just 25 minutes, for USD 1 in cloud computing expenses. This is anticipated to empower researchers to efficiently analyze and interpret data from various sequencing approaches, including whole genome sequencing (WGS), whole exome sequencing (WES), and large panel sequencing. Hence, it is anticipated to impel market growth over the forecast period.

Furthermore, according to the article published by Cryptopolitan in September 2023, in a major advance development, scientists at Pohang University of Science and Technology (POSTECH) have shared their discoveries in the EBioMedicine journal, that they have used machine learning to estimate the chances of a new drug getting approved even before the clinical trials. This is expected to help in understanding the rate of drug failure at the time of clinical trials. Thus, the rising advancements in technology are anticipated to fuel the growth of the market over the forecast period.

However, the complexity of the biological systems and the lack of skilled professionals in the field are anticipated to hinder the growth of the market. Biological systems are incredibly complex, and accurately modeling their behavior can be challenging and requires the presence of skilled and trained professionals. Many biological processes involve complicated networks and interactions, which further add to the complexity of analysis and make computational predictions less reliable in some cases.

Computational Biology Market Report Highlights:

  • Based on service, the software & platform segment dominated the market with a share of 39.06% in 2022, and the same is anticipated to grow at the fastest CAGR over the forecast period. This can be attributed to the rising drug discovery & development and growing demand for personalized medicines
  • Based on application, the clinical trials segment dominated the market with a share of 26.84% in 2022. This was primarily due to an increase in the number of R&D initiatives in this field.
  • Based on end-use, the industrial segment held the largest market share of 62.10% in 2022. This can be attributed to the increasing research activities for drug discovery, target identification, virtual screening, and pharmacokinetic modeling, among other applications
  • In 2022, North America dominated the market with a share of 48.93%, owing to the presence of major market players, and robust healthcare infrastructure. These are anticipated to boost the market for computational biology in the region over the forecast period

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Service Segment
    • 1.2.2. Application Segment
    • 1.2.3. End-use Segment
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Formulation & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2
    • 1.9.3. Objective 3

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Growing Adoption Of Bioinformatics Technology
    • 3.3.2. Advancements In Genomic Research
    • 3.3.3. Increasing Demand For Personalized Medicines
  • 3.4. Market Restraint Analysis
    • 3.4.1. Lack of Skilled Professional
    • 3.4.2. Data Privacy And Security Concerns
  • 3.5. Business Environment Analysis
    • 3.5.1. PESTEL Analysis
    • 3.5.2. Porter's Five Forces Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Service Business Analysis

  • 4.1. Computational Biology Market: Service Movement Analysis
  • 4.2. Databases
    • 4.2.1. Databases Market, 2018 - 2030 (USD Million)
  • 4.3. Infrastructure & Hardware
    • 4.3.1. Infrastructure & Hardware, 2018 - 2030 (USD Million)
  • 4.4. Software Platform
    • 4.4.1. Software Platform Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Computational Biology Market: Application Movement Analysis
  • 5.2. Drug Discovery & Disease Modelling
    • 5.2.1. Drug Discovery & Disease Modelling Market, 2018 - 2030 (USD Million)
    • 5.2.2. Target Identification
      • 5.2.2.1. Target Identification Market, 2018 - 2030 (USD Million)
    • 5.2.3. Target Validation
      • 5.2.3.1. Target Validation Market, 2018 - 2030 (USD Million)
    • 5.2.4. Lead Discovery
      • 5.2.4.1. Lead Discovery Market, 2018 - 2030 (USD Million)
    • 5.2.5. Lead Optimization
      • 5.2.5.1. Lead Optimization Market, 2018 - 2030 (USD Million)
  • 5.3. Preclinical Drug Development
    • 5.3.1. Preclinical Drug Development Market, 2018 - 2030 (USD Million)
    • 5.3.2. Pharmacokinetics
      • 5.3.2.1. Pharmacokinetics Market, 2018 - 2030 (USD Million)
    • 5.3.3. Pharmacodynamics
      • 5.3.3.1. Pharmacodynamics Market, 2018 - 2030 (USD Million)
  • 5.4. Clinical Trials
    • 5.4.1. Clinical Trials Market, 2018 - 2030 (USD Million)
    • 5.4.2. Phase I
      • 5.4.2.1. Phase I Market, 2018 - 2030 (USD Million)
    • 5.4.3. Phase II
      • 5.4.3.1. Phase II Market, 2018 - 2030 (USD Million)
    • 5.4.4. Phase III
      • 5.4.4.1. Phase III Market, 2018 - 2030 (USD Million)
    • 5.4.5. Phase IV
      • 5.4.5.1. Phase IV Market, 2018 - 2030 (USD Million)
  • 5.5. Computational Genomics
    • 5.5.1. Computational Genomics Market, 2018 - 2030 (USD Million)
  • 5.6. Computational Proteomics
    • 5.6.1. Computational Proteomics Market, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End-use Business Analysis

  • 6.1. Computational Biology Market: End-use Movement Analysis
  • 6.2. Academic & Research
    • 6.2.1. Academic & Research Market, 2018 - 2030 (USD Million)
  • 6.3. Industrial
    • 6.3.1. Industrial Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Regional Market Snapshot
  • 7.2. North America
    • 7.2.1. North America Computational Biology Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.2.2.2. Key Country Dynamics
      • 7.2.2.3. Competitive Scenario
    • 7.2.3. Canada
      • 7.2.3.1. Canada Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.2.3.2. Key Country Dynamics
      • 7.2.3.3. Competitive Scenario
  • 7.3. Europe
    • 7.3.1. Europe Computational Biology Market, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.3.2.2. Key Country Dynamics
      • 7.3.2.3. Competitive Scenario
    • 7.3.3. Germany
      • 7.3.3.1. Germany Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.3.3.2. Key Country Dynamics
      • 7.3.3.3. Competitive Scenario
    • 7.3.4. Spain
      • 7.3.4.1. Spain Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.3.4.2. Key Country Dynamics
      • 7.3.4.3. Competitive Scenario
    • 7.3.5. France
      • 7.3.5.1. France Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.3.5.2. Key Country Dynamics
      • 7.3.5.3. Competitive Scenario
    • 7.3.6. Italy
      • 7.3.6.1. Italy Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.3.6.2. Key Country Dynamics
      • 7.3.6.3. Competitive Scenario
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.3.7.2. Key Country Dynamics
      • 7.3.7.3. Competitive Scenario
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.3.8.2. Key Country Dynamics
      • 7.3.8.3. Competitive Scenario
    • 7.3.9. Norway
      • 7.3.9.1. Norway Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.3.9.2. Key Country Dynamics
      • 7.3.9.3. Competitive Scenario
  • 7.4. Asia Pacific
    • 7.4.1. Asia-Pacific Computational Biology Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Japan Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.4.2.2. Key Country Dynamics
      • 7.4.2.3. Competitive Scenario
    • 7.4.3. China
      • 7.4.3.1. China Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.4.3.2. Key Country Dynamics
      • 7.4.3.3. Competitive Scenario
    • 7.4.4. India
      • 7.4.4.1. India Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.4.4.2. Key Country Dynamics
      • 7.4.4.3. Competitive Scenario
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.4.5.2. Key Country Dynamics
      • 7.4.5.3. Competitive Scenario
    • 7.4.6. Thailand
      • 7.4.6.1. Thailand Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.4.6.2. Key Country Dynamics
      • 7.4.6.3. Competitive Scenario
    • 7.4.7. Australia
      • 7.4.7.1. Australia Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.4.7.2. Key Country Dynamics
      • 7.4.7.3. Competitive Scenario
  • 7.5. Latin America
    • 7.5.1. Latin America Computational Biology Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.5.2.2. Key Country Dynamics
      • 7.5.2.3. Competitive Scenario
    • 7.5.3. Mexico
      • 7.5.3.1. Mexico Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.5.3.2. Key Country Dynamics
      • 7.5.3.3. Competitive Scenario
    • 7.5.4. Argentina
      • 7.5.4.1. Argentina Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.5.4.2. Key Country Dynamics
      • 7.5.4.3. Competitive Scenario
  • 7.6. MEA
    • 7.6.1. MEA Computational Biology Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.6.2.2. Key Country Dynamics
      • 7.6.2.3. Competitive Scenario
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.6.3.2. Key Country Dynamics
      • 7.6.3.3. Competitive Scenario
    • 7.6.4. UAE
      • 7.6.4.1. UAE Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.6.4.2. Key Country Dynamics
      • 7.6.4.3. Competitive Scenario
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Computational Biology Market, 2018 - 2030 (USD Million)
      • 7.6.5.2. Key Country Dynamics
      • 7.6.5.3. Competitive Scenario

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share/Position Analysis, 2022
  • 8.4. Company Profiles/Listing
    • 8.4.1. DNAnexus, Inc.
      • 8.4.1.1. Company Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Illumina, Inc.
      • 8.4.2.1. Company Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Thermo Fisher Scientific, Inc.
      • 8.4.3.1. Company Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Schrodinger, Inc.
      • 8.4.4.1. Company Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Compugen
      • 8.4.5.1. Company Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Aganitha AI Inc.
      • 8.4.6.1. Company Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Genedata AG
      • 8.4.7.1. Company Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. QIAGEN
      • 8.4.8.1. Company Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. SIMULATIONS PLUS
      • 8.4.9.1. Company Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Fios Genomics
      • 8.4.10.1. Company Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives